hero image
Lew Lim - VieLight. Toronto, ON, CA

Lew Lim Lew Lim

Founder and CEO | VieLight

Toronto, ON, CANADA

Lew Lim is the founder and CEO of VieLight







Photobiomodulation Lecture 2015 (Low Level Light Therapy) WORLD PREMIERE: Hope for Alzheimer's  (Trailer)



Dr. Lew Lim is the Founder & CEO of Vielight Inc., and is the inventor of the devices offered by the company. He is a leader in translating the science of photobiomodulation (PBM) into wearable and personal use products, particularly in the field of neurology and neuro science. Today, he directs much of his energy in the search of a solution for Alzheimer’s disease and other brain diseases using PBM. He is also actively pursuing to realize the potential of PBM to address other medical conditions and to enhance human potential. His education and training comprises of engineering, neuroscience, natural medicine, finance, accountancy and management. He obtained his degrees and diplomas from University of California at Berkeley, University of Sheffield, Quantum University, Duke University and The Institute of Chartered Management Accountants, UK.

Areas of Expertise (5)

Medical Devices



Corporate Planning


Education (5)

University of California, Berkeley: Graduate Certificate, Engineering 2002

Quantum University: DNM, Natural Medicine

Quantum University: Ph.D., Natural Medicine

Trinity School of Natural Health: Doctor of Naturopathy, Natural Medicine

The University of Sheffield: MBA, Finance

Affiliations (1)

  • MedicLights Research Inc. : President and Founder

Languages (2)

  • English
  • Malay

Media Appearances (1)

Medical startups seek healthy growth abroad

The Globe and Mail  


The technology is based on discoveries made by Vielight's chief executive officer and founder, Lew Lim, who worked in Silicon Valley to pioneer the technique of introducing therapeutic photonic (light) energy into the human body...

view more

Patents (3)

Self-administrable method, system and apparatus for non-invasive neurostimulation therapy of the brain



The present invention is a portable non-invasive apparatus, system, and method for performing light therapy or photobiomodulation upon the brain tissues through the nostrils of a living mammalian subject for the medical purpose of stimulating the brain in-vivo. In marked difference to conventionally known therapeutic procedures, the present invention utilizes the intranasal pathway as the point of...

view more

Method and portable system for non-invasive, in-vivo blood irradiation light therapy



The present invention is a non-invasive apparatus, system, and method for performing irradiation light therapy upon blood circulating within the nostrils of a living mammalian subject. The merit and medical value of the invention resides in its ability to achieve a reversal of red blood cell aggregation in-vivo without invading the tissues or organs of the living subject—a clinical result which...

view more

Using internet content as a means to establish live social networks by linking internet users to each other who are simultaneously engaged in the same and/or similar content



A system and method that uses internet content and/or content metadata as a means to establish social networks. Examples include linking internet users, searchers, viewers and/or listeners of the same and/or similar internet content to each other via a platform that enables any of the following in n-dimensional environments: social networking, communications, sharing, e-commerce, advertising,...

view more

Articles (2)

Intranasal photobiomodulation improves Alzheimer’s condition in case studies

Presented at the NAALT/WALT Conference

September 2014 In photobiomodulation, cells (with mitochondria) that are not in homeostasis normally enters into the process of restoring homeostasis when exposed to low intensity light in the red to near infrared red wavelengths. This same has been observed in the neurons of nerve cells that are under oxidative stress. If low intensity light in the red to near infrared red can reach degenerating neurons, as in...

The potential of intranasal light therapy for brain stimulation

Presented at the NAALT Conference, Palm Beach Gardens, Florida

February 2013 Available evidence supports intranasal light therapy for brain-related conditions such as mild cognitive impairment, Parkinson’s Disease, migraine, stroke. However, the present set of parameters has been based on optimising the results for blood irradiation; which may be holding back its potential for better neurological outcomes. We analysed the literature to arrive at reference parameters for...